{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:52:58Z","timestamp":1790941978147,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T00:00:00Z","timestamp":1172102400000},"content-version":"vor","delay-in-days":7206,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesia"],"published-print":{"date-parts":[[1987,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>A patient with carcinoid syndrome on long\u2010term antiserotonin therapy with parachlorophenylalanine, experienced a flushing attack with hypotension during the prophylactic administration of aprotonin prior to the induction of anaesthesia. When she was subsequently prepared with a long\u2010acting somatostatin analogue, octreotide (Sandostatin, Sandoz SMS 201\u2013995), plasma levels of tumour\u2010released hormones were reduced and anaesthesia for resection of hepatic metastases was uneventful. The advantages of an anaesthetic approach based on inhibition of carcinoid tumour activity, rather than antagonism of released hormones, are discussed.<\/jats:p>","DOI":"10.1111\/j.1365-2044.1987.tb03087.x","type":"journal-article","created":{"date-parts":[[2007,2,23]],"date-time":"2007-02-23T05:47:32Z","timestamp":1172209652000},"page":"627-632","source":"Crossref","is-referenced-by-count":38,"title":["Somatostatin, anaesthesia, and the carcinoid syndrome"],"prefix":"10.1111","volume":"42","author":[{"given":"R. C.","family":"ROY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. F.","family":"CARTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"WRIGHT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,2,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0300-5089(21)00741-0","article-title":"Diarrhoea due to circulating agents","volume":"15","author":"Rambaud J\u2010C","year":"1986","journal-title":"Clinics in Gastroenterology"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609113151109"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.3.267"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198402000-00012"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90087-X"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/292055a0"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312153092406"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609113151102"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.5.433"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.5.438"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607313150504"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-73-4-607"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03025460"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1976.tb11796.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0031-6997(25)06575-5","article-title":"Substance P","volume":"35","author":"Pernow B.","year":"1983","journal-title":"Pharmacological Reviews"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03004887"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1986.tb13026.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1983.tb12026.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1983.tb14053.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1986.tb13228.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197902013000506"},{"key":"e_1_2_1_23_2","first-page":"A556","article-title":"Clinical controlled trial of the effect of ketanserin in carcinoid syndrome","volume":"26","author":"Gustafsen J","year":"1985","journal-title":"Gut"},{"key":"e_1_2_1_24_2","first-page":"633","volume-title":"Goodman and Gilman's The pharmacological hasis of therapeulks","author":"Douglas WW","year":"1985"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-196003000-00011"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198607000-00017"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/55.9.920"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1986.tb13275.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105475"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.7.549"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91348-X"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198701000-00021"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-1-50"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.2.141"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.5.445"},{"key":"e_1_2_1_36_2","first-page":"165","article-title":"Management of anaesthesia during surgery for patients with carcinoid syndrome","volume":"28","author":"Kleine JW","year":"1977","journal-title":"Acta Anaesthesiologica Belgica"}],"container-title":["Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2044.1987.tb03087.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2044.1987.tb03087.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:43:51Z","timestamp":1761669831000},"score":1,"resource":{"primary":{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2044.1987.tb03087.x"}},"subtitle":["Peri\u2010operative administration of a somatostatin analogue to suppress carcinoid tumour activity"],"short-title":[],"issued":{"date-parts":[[1987,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1987,6]]}},"alternative-id":["10.1111\/j.1365-2044.1987.tb03087.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2044.1987.tb03087.x","archive":["Portico"],"relation":{},"ISSN":["0003-2409","1365-2044"],"issn-type":[{"value":"0003-2409","type":"print"},{"value":"1365-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,6]]}}}